We analyzed tumor-infiltrating lymphocytes (TILs) by flow cytometry on day 7 post CAR T-vax treatment and observed substantially increased endogenous CD8+ TILs and a trend toward increased CD4+ cells (Figure 2A). This evidence concerns the gene CD4 and neoplasm.